Show simple item record

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorSerrano Gregori, Maria
dc.contributor.authorClaveria Guiu, Isabel
dc.contributor.authorChoque Apaico, Estefa
dc.contributor.authorFlores-Chavez, Maria
dc.contributor.authorOuaarab Essadek, Hakima
dc.contributor.authorGómez i Prat, Jordi
dc.contributor.authorMolina Romero, Israel
dc.contributor.authorZarzuela Serrat, Francesc
dc.contributor.authorSulleiro, Elena
dc.date.accessioned2024-01-15T07:49:39Z
dc.date.available2024-01-15T07:49:39Z
dc.date.issued2023-12-01
dc.identifier.citationGómez i Prat J, Serrano Gregori M, Claveria Guiu I, Choque E, Flores-Chavez MD, Molina I, et al. Community-based actions in consulates: a new paradigm for opportunities for systematic integration in Chagas disease detection. BMC Infect Dis. 2023 Dec 1;23:847.
dc.identifier.issn1471-2334
dc.identifier.urihttps://hdl.handle.net/11351/10848
dc.descriptionChagas disease; Health community-based strategy; In-situ screening
dc.description.abstractResearch has shown that multidimensional approaches to Chagas disease (CD), integrating its biomedical and psycho-socio-cultural components, are successful in enhancing early access to diagnosis, treatment and sustainable follow-up. For the first time, a consulate was selected for a community-based CD detection campaign. Two different strategies were designed, implemented and compared between 2021 and 2022 at the Consulate General of Bolivia and a reference health facility in Barcelona open to all Bolivians in Catalonia. Strategy 1 consisted in CD awareness-raising activities before referring those interested to the reference facility for infectious disease screening. Strategy 2 offered additional in-situ serological CD screening. Most of the 307 participants were Bolivian women residents in Barcelona. In strategy 1, 73 people (35.8% of those who were offered the test) were screened and 19.2% of them were diagnosed with CD. Additionally, 53,4% completed their vaccination schedules and 28.8% were treated for other parasitic infections (strongyloidiasis, giardiasis, eosinophilia, syphilis). In strategy 2, 103 people were screened in-situ (100% of those who were offered the test) and 13.5% received a CD diagnosis. 21,4% completed their vaccination schedule at the reference health facility and 2,9% were referred for iron deficiency anemia, strongyloidiasis or chronic hepatitis C. The fact that the screening took place in an official workplace of representatives of their own country, together with the presence of community-based participants fueled trust and increased CD understanding. Each of the strategies assessed had different benefits. Opportunities for systematic integration for CD based on community action in consulates may enhance early access to diagnosis, care and disease prevention.
dc.language.isoeng
dc.publisherBMC
dc.relation.ispartofseriesBMC Infectious Diseases;23
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectChagas, Malaltia de - Diagnòstic
dc.subjectCribatge (Medicina)
dc.subjectParticipació comunitària
dc.subject.meshChagas Disease
dc.subject.mesh/diagnosis
dc.subject.meshMass Screening
dc.subject.meshCommunity Participation
dc.titleCommunity-based actions in consulates: a new paradigm for opportunities for systematic integration in Chagas disease detection
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1186/s12879-023-08844-2
dc.subject.decsenfermedad de Chagas
dc.subject.decs/diagnóstico
dc.subject.decscribado sistemático
dc.subject.decsparticipación de la comunidad
dc.relation.publishversionhttps://doi.org/10.1186/s12879-023-08844-2
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Gómez I Prat J, Claveria Guiu I, Ouaarab H] Unitat de Medicina Tropical i Salut Internacional Drassanes-Vall d’Hebron Hospital Universitari, Barcelona, Spain. Servei de Malalties Infeccioses, Vall d’Hebron Hospital Universitari, Barcelona, Spain. International Health Program of the Catalan Institute of Health (PROSICS), Barcelona, Spain. Association of Friends of People With Chagas Disease - ASAPECHA2 International Health Program of the Catalan Institute of Health (PROSICS), Barcelona, Spain. [Serrano Gregori M] Unitat de Medicina Tropical i Salut Internacional Drassanes-Vall d’Hebron Hospital Universitari, Barcelona, Spain. Servei de Malalties Infeccioses, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Choque E] Unitat de Medicina Tropical i Salut Internacional Drassanes-Vall d’Hebron Hospital Universitari, Barcelona, Spain. Servei de Malalties Infeccioses, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Association of Friends of People With Chagas Disease - ASAPECHA2 International Health Program of the Catalan Institute of Health (PROSICS), Barcelona, Spain. [Flores Chavez MD] Mundo Sano Foundation, Barcelona, Spain. Leishmaniasis and Chagas Disease Unit, National Centre for Microbiology, Instituto de Salud Carlos III. Madrid, Barcelona, Spain. [Molina I] International Health Program of the Catalan Institute of Health (PROSICS), Barcelona, Spain. Servei de Malalties Infeccioses, Unitat de Medicina Tropical i Salut Internacional, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Zarzuela F, Sulleiro E] International Health Program of the Catalan Institute of Health (PROSICS), Barcelona, Spain. Servei de Microbiologia, Unitat de Medicina Tropical i Salut Internacional, Vall d’Hebron Hospital Universitari, Barcelona, Spain. PROSICS Barcelona, Barcelona, Spain
dc.identifier.pmid38041069
dc.identifier.wos001123310900001
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record